(Q51668904)

9 April 2018

title

The effect of calcium channel antagonists and bay K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle (English)

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

14 August 2024

author name string

P. S. Foster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7682190

14 August 2024

M. A. Denborough

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7682190

14 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7682190

14 August 2024

publication date

1 April 1993

1 reference

9 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0020711X9390656Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

https://api.elsevier.com/content/article/PII:0020711X9390656Y?httpAccept=text/plain

14 August 2024

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

International Journal of Biochemistry & Cell Biology

14 August 2024

published in

1 reference

9 April 2018

volume

25

1 reference

9 April 2018

issue

4

1 reference

9 April 2018

page(s)

495-504

1 reference

9 April 2018

Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Effects of Calcium-free Solution, Calcium Antagonists, and the Calcium Agonist BAY K 8644 on Mechanical Responses of Skeletal Muscle from Patients Susceptible to Malignant Hyperthermia

14 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia

14 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle.

14 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Effect of diltiazem on spontaneous cyclic Ca2+ release from sarcoplasmic reticulum

14 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Effects of the calcium antagonist gallopamil (D600) upon excitation-contraction coupling in toe muscle fibres of the frog

14 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Further characterization of light and heavy sarcoplasmic reticulum vesicles. Identification of the 'sarcoplasmic reticulum feet' associated with heavy sarcoplasmic reticulum vesicles

14 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Localization and partial characterization of the oligomeric disulfide-linked molecular weight 95,000 protein (triadin) which binds the ryanodine and dihydropyridine receptors in skeletal muscle triadic vesicles

14 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Receptor sites for Ca2+ channel antagonists

14 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Molecular properties of dihydropyridine-sensitive calcium channels

14 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

The pathopharmacology of malignant hyperpyrexia

14 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

The voltage-activation of contraction in skeletal muscle

14 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Transverse tubule calcium regulation in malignant hyperthermia

14 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Abnormal ryanodine receptor channels in malignant hyperthermia

14 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Fatty acids markedly lower the threshold for halothane-induced calcium release from the terminal cisternae in human and porcine normal and malignant hyperthermia susceptible skeletal muscle.

14 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Fatty acids modulate calcium-induced calcium release from skeletal muscle heavy sarcoplasmic reticulum fractions: implications for malignant hyperthermia

14 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

14 August 2024

Malignant hyperpyrexia

20

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle.

14 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Inositol 1,4,5-trisphosphate phosphatase deficiency and malignant hyperpyrexia in swine.

14 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.

14 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane.

14 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Characterization of the terminal cisternae and longitudinal tubules of sarcoplasmic reticulum from malignant hyperpyrexia susceptible porcine skeletal muscle

14 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Identification of a Mutation in Porcine Ryanodine Receptor Associated with Malignant Hyperthermia

14 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

[3H] verapamil binding sites in skeletal muscle transverse tubule membranes

14 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia

14 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

14 August 2024

Malignant hyperthermia

30

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

A new and convenient colorimetric determination of inorganic orthophosphate and its application to the assay of inorganic pyrophosphatase

14 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists

14 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Excitation contraction coupling in skeletal muscle: evidence for a role of slow Ca2+ channels using Ca2+ channel activators and inhibitors in the dihydropyridine series

14 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.

14 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Nifedipine and BAY K inhibit contraction independently from their action on calcium channels

14 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Metabolic error of muscle metabolism after recovery from malignant hyperthermia

14 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Isolation of a terminal cisterna protein which may link the dihydropyridine receptor to the junctional foot protein in skeletal muscle

14 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Purification and reconstitution of the calcium release channel from skeletal muscle

14 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Components of charge movement in rabbit skeletal muscle: the effect of tetracaine and nifedipine.

14 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Calcium currents and asymmetric charge movement in malignant hyperpyrexia

14 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Molecular genetics and malignant hyperthermia.

14 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia.

14 August 2024

43

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Mechanisms of Ca2+ release from sarcoplasmic reticulum of skeletal muscle

14 August 2024

45

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

A study of the action of caffeine, halothane, potassium chloride and procaine on normal human skeletal muscle.

14 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs

14 August 2024

49

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Identification of susceptibility to malignant hyperpyrexia in swine

14 August 2024

50

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

A simplification of the protein assay method of Lowry et al. which is more generally applicable

14 August 2024

51

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Calcium-dependent electrical activity and contraction of voltage-clamped frog single muscle fibres

14 August 2024

52

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Involvement of dihydropyridine receptors in excitation–contraction coupling in skeletal muscle

14 August 2024

53

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Inositol-1,4,5-trisphosphate and malignant hyperthermia

14 August 2024

54

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Possible involvement of inositol-lipid metabolism in malignant hyperthermia

14 August 2024

55

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA.

14 August 2024

56

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

Dantrolene and calcium uptake by the sarcoplasmic reticulum of malignant hyperpyrexia-susceptible pigs

14 August 2024

58

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

The effect of dantrolene on skeletal-muscle sarcoplasmic-reticulum function in malignant hyperpyrexia in pigs

14 August 2024

59

1 reference

https://api.crossref.org/works/10.1016/0020-711X(93)90656-Y

14 August 2024

Identifiers

1 reference

9 April 2018

1 reference

9 April 2018